- ►chestpubs.org MN Levine, G Raskob, RJ Beyth, C Kearon, … - Chest, 2004 - chestjournal.chestpubs.org This chapter about hemorrhagic complications of anticoagulant treatment is part
of the seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy:
Evidence Based Guidelines. Bleeding is the major complication of ... Cited by 1086 - Related articles - BL Direct - All 14 versions
- ►ahajournals.org HP Adams Jr, RJ Adams, T Brott, GJ del … - Stroke, 2003 - Am Heart Assoc In 1994, a panel appointed by the Stroke Council of the American Heart
Association authored guidelines for the management of patients with acute
ischemic stroke. 1 After the approval of the use of intravenous recombinant ... Cited by 870 - Related articles - BL Direct - All 9 versions
J Hirsh, TE Warkentin, SG Shaughnessy, SS … - Chest, 2001 - chestjournal.chestpubs.org Heparin and its derivative, low-molecular-weight heparin (LMWH), are the
anticoagulants of choice when a rapid anticoagulant effect is required, because
their onset of action is immediate when administered by IV injection. Both ... Cited by 743 - Related articles - BL Direct - All 8 versions
JS Ginsberg, I Greer, J Hirsh - Chest, 2001 - chestjournal.chestpubs.org Fatal pulmonary embolism (PE) remains a common cause of maternal mortality.
Maternal mortality from PE can be reduced in two ways: (1) by aggressively
investigating symptomatic women when they present with a clinical suspicion ... Cited by 550 - Related articles - BL Direct - All 24 versions
SM Bates, IA Greer, J Hirsh, JS Ginsberg - Chest, 2004 - Am Coll Chest Phys This chapter about the use of antithrombotic agents during pregnancy is part of
the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy: Evidence
Based Guidelines. Grade 1 recommendations are strong and indicate that the ... Cited by 403 - Related articles - BL Direct - All 13 versions
- ►ahajournals.org J Hirsh, SS Anand, JL Halperin, V Fuster - Circulation, 2001 - Am Heart Assoc Thrombi are composed of fibrin and blood cells and may form in any part of the
cardiovascular system, including veins, arteries, the heart, and the
microcirculation. Because the relative proportion of cells and fibrin ... Cited by 324 - Related articles - BL Direct - All 10 versions
- ►ascopubs.org AK Kakkar, MN Levine, Z Kadziola, NR … - Journal of Clinical Oncology, 2004 - jco.ascopubs.org From the Department of Surgical Oncology and Technology, and Cancer Research UK
Laboratories, Imperial College; Thrombosis Research Institute; and Department of
Surgery, Hammersmith Hospital, London; Mount Vernon Hospital Cancer Centre, ... Cited by 302 - Related articles - BL Direct - All 6 versions
- ►annals.org [PDF] MK Gould, AD Dembitzer, GD Sanders, AM … - Annals of internal medicine, 1999 - Am Coll Physicians Michael K. Gould, MD, MSc; Anne D. Dembitzer, MD; Gillian D. Sanders, PhD; and
Alan M. Garber, MD, PhD ... Background: Low-molecular-weight heparins are
effec- tive for treating venous thrombosis, but their cost- effectiveness ... Cited by 262 - Related articles - BL Direct - All 9 versions
- ►jcojournal.org AYY Lee, FR Rickles, JA Julian, M Gent, RI … - Journal of Clinical Oncology, 2005 - jcojournal.org PATIENTS AND METHODS: Survival data were examined in a posthoc analysis in
patients with solid tumors and venous thromboembolism who were randomly assigned
to dalteparin or a coumarin derivative for 6 months in a multicenter, ... Cited by 248 - Related articles - All 11 versions
SZ Goldhaber, VF Tapson - The American journal of cardiology, 2004 - Elsevier Venous thromboembolism (VTE) comprises deep vein thrombosis (DVT) and pulmonary
embolism (PE) and accounts for >250,000 hospitalizations annually in the United
States.[1 and 2] The most serious complication of DVT is PE, which has a ... Cited by 242 - Related articles - All 4 versions